Table 4. Comparison of Scores at Baseline and Posttreatment/Follow-up for Each Item Included in the K-HSS.

	Baseline	Posttreatment/Follow-up	P value
Patients group (n=25)
Total	12.0 (7.8–18.0)	3.0 (1.0–7.5)	<0.001
K-HSS, #1 (nervousness)	1.0 (0.0–2.0)	0.0 (0.0–1.0)	0.002
K-HSS, #2 (diaphoresis)	1.0 (0.0–2.0)	0.0 (0.0–2.0)	0.017
K-HSS, #3 (heat intolerance)	1.0 (1.0–2.5)	1.0 (0.0–1.0)	0.001
K-HSS, #4 (motor activity)	1.0 (0.0–2.0)	0.0 (0.0–1.0)	0.047
K-HSS, #5 (tremor)	2.0 (0.0–2.0)	0.0 (0.0–0.5)	0.002
K-HSS, #6 (weakness)	1.0 (1.0–2.5)	0.0 (0.0–0.5)	<0.001
K-HSS, #7 (hyperdynamic precordium)	2.0 (1.0–3.0)	0.0 (0.0–2.0)	0.001
K-HSS, #8 (diarrhea)	1.0 (0.0 –1.0)	0.0 (0.0–0.0)	0.003
K-HSS, #9 (weight loss/appetite)	1.0 (0.0–2.5)	0.0 (0.0–1.0)	0.050
K-HSS, #10 (overall function)	1.0 (0.0–2.0)	0.0 (0.0–1.0)	0.002
Control group (n=10)
Total	0.5 (0.0–2.8)	0.0 (0.0–2.0)	0.496
K-HSS, #1 (nervousness)	0.0 (0.0–1.0)	0.0 (0.0–1.0)	1.000
K-HSS, #2 (diaphoresis)	0.0 (0.0–0.3)	0.0 (0.0–0.0)	0.157
K-HSS, #3 (heat intolerance)	0.0 (0.0–0.0)	0.0 (0.0–0.0)	1.000
K-HSS, #4 (motor activity)	0.0 (0.0–0.3)	0.0 (0.0–0.3)	1.000
K-HSS, #5 (tremor)	0.0 (0.0–0.0)	0.0 (0.0–0.0)	1.000
K-HSS, #6 (weakness)	0.0 (0.0–0.0)	0.0 (0.0–0.0)	1.000
K-HSS, #7 (hyperdynamic precordium)	0.0 (0.0–0.0)	0.0 (0.0–0.0)	1.000
K-HSS, #8 (diarrhea)	0.0 (0.0–0.0)	0.0 (0.0–0.0)	0.317
K-HSS, #9 (weight loss/appetite)	0.0 (0.0–0.3)	0.0 (0.0–0.0)	0.317
K-HSS, #10 (overall function)	0.0 (0.0–0.0)	0.0 (0.0–0.0)	0.317

Values are expressed as median (interquartile range).

K-HSS, Korean version of the hyperthyroidism symptom scale.